🕒 Tuesday 4 August 2026 Tue, 4 Aug 2026

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Embark Early Education has secured a $4 million placement from a US institutional investor to fuel potential asset acquisitions, issuing 10 million new shares at $0.40 each under its 10% placement capacity.

Amplia Therapeutics has teamed up with Eli Lilly to test its FAK inhibitor narmafotinib alongside Lilly’s KRAS G12C inhibitor olomorasib in advanced non-small cell lung cancer, marking a strategic expansion beyond pancreatic and ovarian cancers.

Reckon Limited maintained steady revenue and EBITDA in constant currency during the first half of FY26, while NPAT rose 6%, driven by strong growth in its cloud products Reckon One and Billing Workflows alongside strategic AI investments.

Global Lithium Resources has secured the Mining Development and Closure Proposal approval for its Manna Lithium Project, paving the way for early works and infrastructure development ahead of a planned Final Investment Decision in late 2026.

Taruga Minerals' preliminary metallurgical testwork at the Weioko Gold Deposit reveals free-milling gold with recoveries exceeding 90% across grades, and silver emerging as a significant co-product, setting a solid technical foundation for upcoming drilling.

Marmota Limited is ramping up its maiden drilling program at the Greenewood gold discovery in South Australia, increasing planned drilling from 20,000m to 26,000m to extend mineralisation and support a scoping study.

GreenX Metals has expanded its Eleonore North Project with two new licences covering about 1,600 km² in East Greenland, targeting intrusion-related gold and critical minerals like tungsten. Historical data shows high gold grades up to 50 g/t, with fieldwork results due this quarter.

Mandrake Resources has strategically refined its Utah Lithium Project tenure by securing three key SITLA leases in the project’s central zone and relinquishing marginal blocks, positioning itself for upcoming bulk lithium brine production and technical evaluation.

Hot Chili Limited expands its Costa Fuego copper-gold project with significant drilling success at La Verde, underpinning a strong Preliminary Feasibility Study and strategic water infrastructure plans.

Peregrine Gold has expanded the known gold-bearing paleo gravel strike at its Capricorn Prospect to approximately 4 kilometres, uncovering a new potential gold source and advancing plans for small-scale mining operations.

OM Holdings' subsidiary OM Materials has locked in a binding take-or-pay deal to purchase up to 1.1 million tonnes per annum of manganese concentrate from Element 25's Butcherbird Mine, underpinning Element 25's expansion and financing plans.

Rua Bioscience has gained regulatory approval in New Zealand for five new medicinal cannabis products, setting the stage for domestic sales and advancing its strategy to integrate local cannabis genetics.

EROAD has appointed David Leach as CEO, effective October 2026, aiming to leverage his SaaS scaling expertise to accelerate growth and develop an AI-native platform.

F&C Investment Trust delivered a 12.4% net asset value total return for H1 2026, narrowly trailing the FTSE All-World Index. The trust declared a 0.99p interim dividend and announced a chairman succession as it navigates AI-led market dynamics and geopolitical volatility.